Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Policy & Regulation
上一篇:Hindus,... bulc arupirT siht ta ajuP agru
下一篇:Four... oxeN rednel otpyrc fo eborp ni